Early but reversible haemostatic changes in a-symptomatic females expressing COVID-19 antibodiesCOVID-19 항체를 발현하는 무증상 여성의 초기이지만 가역적인 지혈 변화Article Published on 2022-09-012022-09-12 Journal: Thrombosis research [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] age and gender aggregation antibody Antibody Response Asymptomatic COVID-19 carried change changes in circulating coagulation parameter Cohort cohort study Control coronavirus country COVID-19 COVID-19 antibody COVID-19 pandemic COVID-19-associated coagulopathy Effect effort expressing extracellular vesicle female Female patients globe Haemoglobin highest IgM and IgG individual Infection initial intensive care treatment male Mortality participant Participants pathway Platelet platelet activation Platelet responsiveness. positive positive COVID-19 Prevalence Prothrombin time risk serious complication significant decrease significant increase Spread subject unique vaccination Vaccine viral mutation were assessed with COVID-19 [DOI] 10.1016/j.thromres.2022.07.012 PMC 바로가기 [Article Type] Article
Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019Article Published on 2022-05-012023-07-06 Journal: British Journal of Pharmacology [Category] COVID19(2023년), [키워드] acute respiratory distress syndrome COVID-19-associated coagulopathy PAR1 PAR2 Sepsis [DOI] 10.1111/bph.15587 PMC 바로가기
Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study코로나바이러스 질병 2019에서 저분자량 헤파린 사용은 바이러스 지속성 감소와 관련이 있습니다: 후향적 다기관 관찰 연구Observational Study Published on 2021-12-012022-09-10 Journal: Cardiovascular Research [Category] SARS, 바이오마커, 임상, [키워드] (cfDNA) 95% confidence interval anticoagulation attenuation Biomarker cell death cell-free DNA cfDNA Chain Reaction Coagulopathy contraindications coronavirus disease Coronavirus disease 2019 Course COVID-19 COVID-19 patient COVID-19-associated coagulopathy D-dimer decrease different time point different time points Effect evaluate evaluated haemostasis hazard ratio heparin Hospitalization Hospitalized hospitalized COVID-19 patient hypercoagulability interquartile interquartile range LMWH Low-molecular-weight heparin marker mechanism Mortality multicentre multivariable Cox regression no effect NOAC oral anticoagulant outcome Patient patients with COVID-19 plasma polymerase chain polymerase chain reaction Quantitative quantitative polymerase chain reaction reduced reduction Region responsible retrospective SARS-CoV-2 viral persistence subset survival the cell Thromboinflammation time Viral viral persistence virus was collected [DOI] 10.1093/cvr/cvab308 PMC 바로가기 [Article Type] Observational Study
Recurrence of Upper Extremity Deep Vein Thrombosis Secondary to COVID-19Case Report Published on 2021-05-112022-10-28 Journal: Viruses [Category] COVID-19, [키워드] coagulation disorders COVID-19 COVID-19 infection COVID-19 patients COVID-19-associated coagulopathy deep Deep vein thrombosis DVT events extremity hypercoagulable states Hyperinflammatory induce occur Patient recurrence reported resulting SARS-CoV-2 secondary to upper Vein venous thromboembolic Venous Thromboembolism while [DOI] 10.3390/v13050878 PMC 바로가기 [Article Type] Case Report
The roles and potential therapeutic implications of C5a in the pathogenesis of COVID-19-associated coagulopathyReview Published on 2021-04-012023-07-13 Journal: Cytokine & growth factor reviews [Category] SARS, [키워드] anaphylatoxin C5a complement system COVID-19-associated coagulopathy Pathogenesis [DOI] 10.1016/j.cytogfr.2020.12.001 PMC 바로가기 [Article Type] Review
A Case of Severe Acute Pancreatitis Secondary to COVID-19 Infection in a 30-Year-Old Male PatientInternal Medicine Published on 2020-11-262022-10-31 Journal: Cureus [Category] COVID-19, [키워드] abdomen abdominal pain Admission association Chest clinical condition clinical evaluation coronavirus coronavirus 2 Coronavirus disease 2019 COVID-19 COVID-19 pneumonia covid-19 respiratory failure COVID-19 test COVID-19-associated coagulopathy CT scan diarrhea dry cough Dyspnea edema Fever gastrointestinal complaints highlight homogenous hypoxia inflammatory changes interstitial lung male Mild nausea notable pancreatic Pancreatitis Patient positive presenting prophylactic and therapeutic anticoagulation respiratory SARS-CoV-2 secondary to stroke and covid-19 Tachycardia vomiting wheezing worsening X-ray [DOI] 10.7759/cureus.11718 PMC 바로가기 [Article Type] Internal Medicine
Coronavirus-Associated Coagulopathy: Lessons From SARS-CoV1 and MERS-CoV for the Current SARS-CoV2 PandemicInternal Medicine Published on 2020-11-032022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute respiratory syndrome appear assist chest imaging clinical condition Clinical course clinician Coagulopathies Consensus Conservative management coronavirus coronavirus disease COVID-19 COVID-19-associated coagulopathy current Cytokine storm discharged home Effects elevated endothelial evaluate female Fever form Hospital stay hypercoagulability Hypothyroidism incidence Inflammation Inflammatory marker initial initiated intra-alveolar intubation left upper lobe lesson low molecular weight main pulmonary artery management manuscript mechanical ventilation MERS-CoV Middle East multifactorial nasopharyngeal nonproductive cough Pathogenesis pathophysiology Patient patients PCR test pro-inflammatory state Prophylactic recommendation remained respiratory syndrome coronavirus risk SARS virus SARS-CoV2 SARS-CoV2 infection SARS-CoV2- Seven stroke suggested systemic anticoagulation the timing therapeutic anticoagulation thrombosis Thrombotic complications tomography transferred while worsened [DOI] 10.7759/cureus.11310 PMC 바로가기 [Article Type] Internal Medicine
Approach to the Patient with COVID-19-Associated Thrombosis: A Case-Based ReviewCOVID-19 관련 혈전증 환자에 대한 접근: 사례 기반 검토Review Published on 2020-10-012022-09-11 Journal: The oncologist [Category] SARS, 바이오마커, [키워드] anticoagulation approach caused characterized Clinical practice coagulation test Coagulopathy coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19-associated coagulopathy current D-dimer levels diagnostic distill elevated Evidence global pandemic hospitalized patient hyperfibrinogenemia implication information management management guideline management guidelines Mild Novel coronavirus novel coronavirus SARS-CoV-2 Patient patients with COVID-19 populations Prophylactic prophylactic anticoagulation prophylactic doses prothrombin Prothrombin time Randomized controlled trial receive reported respiratory Respiratory illness Retrospective study review SARS-CoV-2 severe respiratory illness Standard dose Support Surveillance thrombocytopenia Thromboembolism thrombosis Variation variations [DOI] 10.1634/theoncologist.2020-0682 PMC 바로가기 [Article Type] Review
COVID-19-Associated Systemic Thromboembolism: A Case Report and Review of the LiteratureReview Published on 2020-01-012023-07-05 Journal: Cardiorenal Medicine [Category] SARS, [키워드] AKI anticoagulation ARDS COVID-19 COVID-19-associated coagulopathy Cytokine release syndrome D-dimer SARS-CoV-2 Thromboembolism thrombotic microangiopathy [DOI] 10.1159/000511800 PMC 바로가기 [Article Type] Review